Home » Expertise
» Area of Law
» Litigation and Dispute Resolution
» Pharmaceutical and Medical Devices - Publications
There's emerging evidence of potential toxicity of zinc oxide and titanium dioxide nanoparticles. What will this mean for manufacturers of products containing nanoparticles generally, asks Dr Michael Maxwell & Dr Benjamin De Campo.
2 Feb 2012
The Senate appears likely to reject the proposal to exclude "biological materials" from patentable subject matter in Australia, as Deborah Polites and Richard Hoad explain.
13 Oct 2011
In the recent case between Sanofi-Aventis Australia Pty Ltd and Apotex Pty Ltd [2011] FCA 846, the Federal Court of Australia addressed for the first time the issues of copyright subsistence and infringement in relation to product information documents (PI) for pharmaceutical products.
2 Aug 2011
Colin Loveday and Greg Williams explain the basics of Australian pharmaceutical advertising law in this chapter excerpted from Global Legal Group's International Comparative Legal Guide to Pharmaceutical Advertising 2011.
8 Jul 2011
The Advisory Council on Intellectual Property has released its Report into Patentable Subject Matter, and its recommendations, while not radical, would go some way to clarifying the law of patents in Australia if adopted.
22 Feb 2011
